Medicines and vaccines that should have a zero rate in tax reform

Medicines and vaccines that should have a zero rate in tax reform
Descriptive text here
-

The government presented to Congress this week the regulatory project for tax reform approved in 2023. The document, which has more than 300 pages and 500 articles, details some of the sectors that will have special rates. The average tax rate Value Added Tax (VAT) will be 26.5%, according to calculations by the Ministry of Finance.

A series of vaccines It is medicines will have its rate zeroed according to the project. The list includes vaccines against covid-19, dengue, yellow fever, flu, cholera, polio and measles. Insulin, used to treat diabetes, and the antiviral drug abacavir, used against the HIV virus, will also have their tax rates reset.

Among the medicines, the project foresees that omeprazole, the anxiolytic lorazepam, the high blood pressure medicine losartan, metmorphine, used for diabetes), the anti-inflammatory prednisone and the sexual impotence medicine tadafilia will have their rates reset at this first moment.

The regulatory phase of the tax reform was handed over to Congress last Wednesday, the 24th. The text needs to be evaluated by the Chamber of Deputies and, later, by the Federal Senate.

Continues after advertising

The political environment in Brasília is not the most favorable for the Planalto. The President of the Chamber, Arthur Lira (PP-AL), publicly criticized the work of Alexandre Padilha, Minister of Institutional Relations, whom he referred to as “a personal dislike”. To make matters worse, the judicialization of the payroll tax exemption for 17 sectors of the economy displeased the president of the Senate, Rodrigo Pacheco (PSD-MG). The trial was suspended by the Federal Supreme Court after Minister Luiz Fux requested a review of the case. The score was 5 votes to 0 for maintaining Minister Cristiano Zanin’s individual decision to suspend the exemption approved by the Senate.

(with Brazil Agency)

-

-

NEXT MPAM’s general ombudsman carries out a technical visit and discusses the defense of women’s rights at Aleam
-

-

-